Table 3.
Blood parameters in patients with hepatocellular carcinoma
| Parameter | |
|---|---|
| Hb (g/dL) | 11.3 (2.1) |
| TLC (cells per mm3) | 7300 (2900–26400) |
| PLT (cells per mm3) | 1.645 (0.2500–17.1) |
| TB (mg/dL) | 1.500 (0.17–24.10) |
| Alb (g/dL) | 3.280 (1.7–4.9) |
| AST (U/L) | 77.00 (4–810) |
| ALT (U/L) | 39 (6–731) |
| ALP (U/L) | 157.0 (40–1187) |
| AST (> 2 times UNL) (%) | 45.1% |
| ALT (> 2 times UNL) (%) | 12.7% |
| ALP (> 2 times UNL) (%) | 49.3% |
| INR >1.5 (%) | 14.5% |
| AFP (ng/mL) | 353.3 (0.8–395444) |
| AFP < 20 ng/mL (%) | 27.4% |
| 20–400 ng/mL (%) | 23.7% |
| 400–1000 ng/mL (%) | 8.3% |
| >1000 ng/mL (%) | 40.6% |
Hb hemoglobin expressed in g/dL mean (SD), TLC total leukocyte count, PLT platelet count, TB total bilirubin, Alb albumin, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, INR international normalized ratio, AFP alpha- fetoproteinin, UNL upper normal limit, TLC PLT, TB, Alb, AST, ALT, ALP and AFP expressed as median (interquartile range), % of patients with AFP levels <20, 20–400, 400–1000, and >1000 ng/mL